FDA to explore gender differences in effects of CBD, other cannabinoids

The U.S. Food and Drug Administration’s Office of Women’s Health announced a Nov. 19 “multidisciplinary scientific conference” for medical professionals and members of the public to talk about how genders might be affected differently by cannabinoids.

FDA to explore gender differences in effects of CBD, other cannabinoids is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs